Water Tower Research Manager Director Thierry Wuilloud talks to Proactive about his Water Tower Research Fire Side Chat series with biopharmaceutical company Theratechnologies (NASDAQ:THTX).
Wuilloud says he's looking forward to the Montreal, Canada-based group to keep the momentum with its marketed drugs, he would like to see its run-rate of sales continue, and is hopeful for the firm to make continued progress on its two lead drugs within the pipeline, and advancements with the FDA.